📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. (2021)

First Author: Jiménez-Villegas J

Attributed to: MICA: M102, A Combined NRF2 and HSF1 Activator for the Treatment of Motor Neuron Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.freeradbiomed.2021.07.022

PubMed Identifier: 34314817

Publication URI: http://europepmc.org/abstract/MED/34314817

Type: Journal Article/Review

Volume: 173

Parent Publication: Free radical biology & medicine

ISSN: 0891-5849